Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Schizophrenia Study In Adults

ClinicalTrials.gov ID: NCT00049946

Public ClinicalTrials.gov record NCT00049946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Double-Dummy, Placebo-Controlled, Randomized, Parallel Group Evaluation of the Efficacy and Safety of a Fixed-Dose of Talnetant Versus Placebo Versus Risperidone in Subjects With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Placebo Controlled Study For Patients With Schizophrenia

Study identification

NCT ID
NCT00049946
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
231 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2002
Primary completion
Mar 31, 2003
Completion
Mar 31, 2003
Last update posted
Aug 15, 2017

2002 – 2003

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
30
Facility City State ZIP Site status
GSK Clinical Trial Call Center Scottsdale Arizona 85251
GSK Clinical Trial Call Center Cerritos California 90703
GSK Clinical Trial Call Center Chula Vista California 91910
GSK Clinical Trial Call Center Garden Grove California 92845
GSK Clinical Trial Call Center Orange California 92868
GSK Clinical Trial Call Center Pico Rivera California 90660
GSK Clinical Trial Call Center Rosemead California 91770
GSK Clinical Trial Call Center Sacramento California 95823
GSK Clinical Trial Call Center San Diego California 92123
GSK Clinical Trial Call Center San Diego California 92126
GSK Clinical Trial Call Center New Britain Connecticut 06050
GSK Clinical Trial Call Center New Haven Connecticut 06519
GSK Clinical Trial Call Center Washington D.C. District of Columbia 20016
GSK Clinical Trial Call Center North Miami Florida 33161
GSK Clinical Trial Call Center Tampa Florida 33613
GSK Clinical Trial Call Center Winter Park Florida 32789
GSK Clinical Trial Call Center Hoffman Estates Illinois 60194
GSK Clinical Trial Call Center Greenwood Indiana 46143
GSK Clinical Trial Call Center Shreveport Louisiana 71101
GSK Clinical Trial Call Center Clementon New Jersey 08021
GSK Clinical Trial Call Center Hollis New York 11423
GSK Clinical Trial Call Center Butner North Carolina 27509
GSK Clinical Trial Call Center Raleigh North Carolina 27603
GSK Clinical Trial Call Center Cincinnati Ohio 45267
GSK Clinical Trial Call Center Cleveland Ohio 44109
GSK Clinical Trial Call Center Norman Oklahoma 73069
GSK Clinical Trial Call Center Oklahoma City Oklahoma 73103
GSK Clinical Trial Call Center Nashville Tennessee 37212
GSK Clinical Trial Call Center Austin Texas 78729
GSK Clinical Trial Call Center Bellaire Texas 77401
GSK Clinical Trial Call Center Terrell Texas 75160

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00049946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 15, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00049946 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →